Cell Source, Inc. (CLCS)

0.93 +0.13 (+16.25%) USD  |  OTCM  |  Apr 16, 16:00
More

Cell Source FCF to Assets (TTM)

FCF to Assets (TTM) Chart

View FCF to Assets (TTM) for CLCS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View FCF to Assets (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

FCF to Assets (TTM) Range, Past 5 Years

View FCF to Assets (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

FCF to Assets (TTM) Benchmarks

View FCF to Assets (TTM) Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Atossa Therapeutics, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
Kiora Pharmaceuticals, Inc. Upgrade